BioMaxima S.A.
WSE: BMX.WA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Warsaw Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Lukasz Urban
- Employees
- 115
- Headquarters
- Lublin, Poland
- IPO year
- 2010
- Market cap
- PLN 48.5M
- Website
- https://www.biomaxima.com
Loading BMX…
Loading profile data…Frequently asked questions about BMX
What does BioMaxima S.A. (BMX.WA) do?
BioMaxima S.A. manufactures and distributes reagents for in vitro diagnostics in Poland. Its primary products include diagnostic reagents and analyzers for clinical chemistry; rapid tests and readers for detecting infectious diseases, cancer markers, cardiac markers, and drugs of abuse; urine analysis systems; hematology analyzers and reagents;...
Where does BMX.WA trade?
BioMaxima S.A. (BMX.WA) trades on the Warsaw Stock Exchange.
What sector is BMX.WA in?
BioMaxima S.A. (BMX.WA) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of BioMaxima S.A.?
Lukasz Urban is the chief executive officer of BioMaxima S.A. (BMX.WA).
Where is BioMaxima S.A. headquartered?
BioMaxima S.A. is headquartered in Poland.
Does BMX.WA pay a dividend?
BioMaxima S.A. (BMX.WA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BMX.WA go public?
BioMaxima S.A. (BMX.WA) completed its initial public offering in 2010.